PRA Health Sciences, Inc.
(NASDAQ : PRAH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 4.60%191.957.5%$444.90m
TALTAL Education Group -4.53%5.800.7%$320.95m
BTBTBit Digital, Inc. 19.56%10.760.0%$247.77m
STMPStamps.com, Inc. 0.13%327.1824.0%$239.35m
FLTFLEETCOR Technologies, Inc. -0.62%256.633.6%$175.66m
EFXEquifax, Inc. -0.45%259.432.0%$157.67m
CPRTCopart, Inc. -0.68%146.004.4%$124.79m
PAGSPagSeguro Digital Ltd. 3.78%57.540.0%$117.22m
CRLCharles River Laboratories International, Inc. 0.30%408.144.5%$104.28m
FOURShift4 Payments, Inc. 0.48%89.620.0%$98.32m
CHGGChegg, Inc. 0.87%89.4113.4%$77.01m
BRBroadridge Financial Solutions, Inc. 0.01%173.501.5%$75.25m
PPDPPD, Inc. 0.49%46.350.0%$74.81m
CLVTClarivate Plc 0.20%22.850.0%$72.77m
SYNHSyneos Health, Inc. -0.97%88.800.0%$57.54m

Company Profile

PRA Health Sciences is a full-service global contract research organization providing a broad range of product development and data solution services to pharmaceutical and biotechnology companies around the world. PRA Health Sciences' global operations span more than 90 offices across North America, Europe, Asia, Latin America, South Africa, Australia, and the Middle East. PRA’s 17,000+ employees have participated in more than 3,800 clinical trials and have supported pivotal trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 85 products since the year 2000.